trending Market Intelligence /marketintelligence/en/news-insights/trending/F_WODYfh-8KVVb9BvaubiQ2 content esgSubNav
In This List

AmerisourceBergen fiscal Q3 earnings up 9.1% YOY; FY'19 guidance raised

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AmerisourceBergen fiscal Q3 earnings up 9.1% YOY; FY'19 guidance raised

AmerisourceBergen Corp. said its adjusted net income for the third quarter ended June 30 rose 9.1% year over year to $371.7 million from $340.6 million.

EPS came in at $1.76, up 14.3% from $1.54 a year earlier.

The S&P Global Market Intelligence consensus normalized EPS estimate in the quarter is $1.62.

The Chesterbrook, Pa.-based healthcare distributor booked a 4.9% yearly increase on its revenue with $45.24 billion from $43.14 billion.

On a GAAP basis, net income climbed 9.5% on an annual basis to $302.0 million, or $1.43 per share, from $275.8 million, or $1.25 per share.

For fiscal year 2019, AmerisourceBergen raised its adjusted EPS outlook in the range of $7.00 to $7.10, from previous guidance in the range of $6.70 to $6.90.

The S&P Global Market Intelligence consensus normalized EPS estimate for the fiscal year is $6.85.